Lung - Hypertrophy, Smooth Muscle
comment:
Bronchial smooth muscle hypertrophy ( Figure 1

recommendation:
Lung, Smooth muscle - Hypertrophy should be diagnosed and assigned a severity grade. A site modifier (i.e., bronchus or bronchiole) should be included to indicate which type of airway is affected. If both types of airways are affected, the site modifier may be omitted and the affected airways described in the pathology narrative. Associated lesions, such as inflammation or fibrosis, should be diagnosed separately. In some cases, where the smooth muscle hypertrophy is a minor component of a more prominent inflammatory or reactive process, the smooth muscle hypertrophy may be described in the pathology narrative as a component of that process, in lieu of a diagnosis. If hyperplasia of the smooth muscle cells is present concurrently, it may be described in the pathology narrative.references:
Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3:507-511. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/2223105
Ebina M, Yaegashi H, Chiba R, Takahashi T, Motomiya M, Tanemura M. 1990. Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. Am Rev Respir Dis 141:1327-1332. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/2187387
Heard BE, Hossain S. 1973. Hyperplasia of bronchial smooth muscle in asthma. J Pathol 110:319-332.
Web page last updated on: December 03, 2015